Repare Therapeutics Inc. (RPTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 2.65M | -16.34M | -29.13M | -27.32M | -30.54M | -30.51M | 11.93M | -28.16M | -32.87M | -34.35M | -31.79M | -29.64M |
| Operating CF Margin % | 22.81% | -6536.8% | - | - | - | -2843.8% | 22.77% | -215.8% | -1522.46% | -113.54% | -559.81% | -162.86% |
| Operating CF Growth % | 108.68% | 46.44% | -344.16% | 2.96% | 7.09% | 11.16% | 137.54% | 5% | -137.29% | -21.82% | -5.93% | -42.91% |
| Net Income | 3.26M | -16.74M | -30.04M | -28.67M | -34.41M | -34.77M | 13.16M | -28.03M | -18.88M | -11.95M | -34.94M | -31.66M |
| Depreciation & Amortization | 72K | 1.04M | 1.19M | 454K | 478K | 488K | 501K | 506K | 498K | 1.05M | 982K | 1.02M |
| Stock-Based Compensation | 0 | 2.07M | 3.98M | 4.93M | 5.25M | 6.52M | 6.47M | 6.36M | 6.38M | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.8M | -1.87M | 0 | 0 | 7.48M |
| Other Non-Cash Items | -1.79M | -2.26M | 24K | -267K | -719K | -1.1M | -704K | 9.71M | 551K | 4.17M | 4.29M | 3.57M |
| Working Capital Changes | 1.11M | -445K | -4.28M | -3.77M | -1.14M | -1.65M | -7.5M | -5.9M | -19.55M | -27.62M | -2.12M | -10.04M |
| Change in Receivables | 1.46M | 146K | 160K | 1.47M | 336K | 110K | 1.11M | -775K | 1.55M | 1.75M | -2.74M | 9.41M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.55M | 0 | 0 | 0 |
| Change in Payables | -2.67M | 1.72M | -1.34M | -7.03M | 3.47M | 354K | 4.43M | -2.65M | 158K | 2.41M | 2.02M | -8.41M |
| Cash from Investing | 2.54M | -586K | 28.79M | 31.59M | 31.08M | 7.12M | -20.32M | 31.88M | 24.5M | 28.35M | -6.69M | 34.06M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -398K | 0 | -1.06M | -475K | 1.72M |
| CapEx % of Revenue | - | - | - | - | - | - | - | 3.05% | - | 3.52% | 8.37% | 9.45% |
| Acquisitions | 0 | 1M | 0 | 0 | 0 | 0 | 0 | -32.28M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32.28M | 0 | 0 | 0 | 0 |
| Cash from Financing | 30K | 0 | 79K | 1K | 166K | 0 | 375K | 105K | 284K | 40K | 413K | 165K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 30K | 0 | 79K | 1K | 166K | 0 | 375K | 105K | 284K | 40K | 413K | 165K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 79K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 5.17M | -16.8M | -262K | 4.18M | 721K | -23.4M | -8.05M | 3.9M | -8.18M | -5.92M | -38.06M | 4.33M |
| Free Cash Flow | 2.65M | -16.34M | -29.13M | -27.32M | -30.54M | -30.51M | 11.93M | -28.55M | -32.87M | -35.41M | -32.26M | -27.92M |
| FCF Margin % | 22.81% | -6536.8% | - | - | - | -2843.8% | 22.77% | -218.85% | -1522.46% | -117.06% | -568.18% | -153.41% |
| FCF Growth % | 108.68% | 46.44% | -344.16% | 4.31% | 7.09% | 13.83% | 136.99% | -2.28% | -137.4% | -18.98% | -5.8% | -33.55% |
| FCF per Share | 0.06 | -0.38 | -0.68 | -0.64 | -0.72 | -0.72 | 0.27 | -0.68 | -0.78 | -0.84 | -0.77 | -0.66 |
| FCF Conversion (FCF/Net Income) | 0.81x | 0.98x | 0.97x | 0.95x | 0.89x | 0.88x | 0.91x | 1.00x | 1.74x | 2.88x | 0.91x | 0.94x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |